Cafournet, C.; Zanin, S.; Guimier, A.; Hully, M.; Assouline, Z.; Barcia, G.; de Lonlay, P.; Steffann, J.; Munnich, A.; Bonnefont, J.-P.;
et al. Novel ELAC2 Mutations in Individuals Presenting with Variably Severe Neurological Disease in the Presence or Absence of Cardiomyopathy. Life 2023, 13, 445.
https://doi.org/10.3390/life13020445
AMA Style
Cafournet C, Zanin S, Guimier A, Hully M, Assouline Z, Barcia G, de Lonlay P, Steffann J, Munnich A, Bonnefont J-P,
et al. Novel ELAC2 Mutations in Individuals Presenting with Variably Severe Neurological Disease in the Presence or Absence of Cardiomyopathy. Life. 2023; 13(2):445.
https://doi.org/10.3390/life13020445
Chicago/Turabian Style
Cafournet, Cérane, Sofia Zanin, Anne Guimier, Marie Hully, Zahra Assouline, Giulia Barcia, Pascale de Lonlay, Julie Steffann, Arnold Munnich, Jean-Paul Bonnefont,
and et al. 2023. "Novel ELAC2 Mutations in Individuals Presenting with Variably Severe Neurological Disease in the Presence or Absence of Cardiomyopathy" Life 13, no. 2: 445.
https://doi.org/10.3390/life13020445
APA Style
Cafournet, C., Zanin, S., Guimier, A., Hully, M., Assouline, Z., Barcia, G., de Lonlay, P., Steffann, J., Munnich, A., Bonnefont, J.-P., Rötig, A., Ruzzenente, B., & Metodiev, M. D.
(2023). Novel ELAC2 Mutations in Individuals Presenting with Variably Severe Neurological Disease in the Presence or Absence of Cardiomyopathy. Life, 13(2), 445.
https://doi.org/10.3390/life13020445
